Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration
Identifieur interne : 002112 ( PascalFrancis/Corpus ); précédent : 002111; suivant : 002113Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration
Auteurs : K. Henkel ; J. Karitzky ; M. Schmid ; I. Mader ; G. Glatting ; J. W. Unger ; B. Neumaier ; A. C. Ludolph ; S. N. Reske ; G. B. LandwehrmeyerSource :
- Movement disorders [ 0885-3185 ] ; 2004.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
Positron emission tomography (PET) using [11C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [11C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [11C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 04-0455135 INIST |
---|---|
ET : | Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration |
AU : | HENKEL (K.); KARITZKY (J.); SCHMID (M.); MADER (I.); GLATTING (G.); UNGER (J. W.); NEUMAIER (B.); LUDOLPH (A. C.); RESKE (S. N.); LANDWEHRMEYER (G. B.) |
AF : | Department of Neurology University of Ulm/Ulm/Allemagne (1 aut., 2 aut., 6 aut., 8 aut., 10 aut.); Department of Nuclear Medicine, University of Ulm/Ulm/Allemagne (1 aut., 2 aut., 3 aut., 5 aut., 7 aut., 9 aut.); Department of Neuroradiology, University of Tübingen/Tübingen/Allemagne (4 aut.) |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 7; Pp. 817-821; Bibl. 13 ref. |
LA : | Anglais |
EA : | Positron emission tomography (PET) using [11C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [11C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [11C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD. |
CC : | 002B17 |
FD : | Dégénérescence; Microglie; Positon; Système nerveux pathologie; Tomoscintigraphie |
FG : | Névroglie; Exploration radioisotopique |
ED : | Degeneration; Microglia; Positron; Nervous system diseases; Emission tomography |
EG : | Neuroglia; Radionuclide study |
SD : | Degeneración; Microglia; Positrón; Sistema nervioso patología; Tomocentelleografía |
LO : | INIST-20953.354000113929420110 |
ID : | 04-0455135 |
Links to Exploration step
Pascal:04-0455135Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Imaging of activated microglia with PET and [<sup>11</sup>
C]PK 11195 in corticobasal degeneration</title>
<author><name sortKey="Henkel, K" sort="Henkel, K" uniqKey="Henkel K" first="K." last="Henkel">K. Henkel</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Karitzky, J" sort="Karitzky, J" uniqKey="Karitzky J" first="J." last="Karitzky">J. Karitzky</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmid, M" sort="Schmid, M" uniqKey="Schmid M" first="M." last="Schmid">M. Schmid</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mader, I" sort="Mader, I" uniqKey="Mader I" first="I." last="Mader">I. Mader</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neuroradiology, University of Tübingen</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Glatting, G" sort="Glatting, G" uniqKey="Glatting G" first="G." last="Glatting">G. Glatting</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Unger, J W" sort="Unger, J W" uniqKey="Unger J" first="J. W." last="Unger">J. W. Unger</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Neumaier, B" sort="Neumaier, B" uniqKey="Neumaier B" first="B." last="Neumaier">B. Neumaier</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ludolph, A C" sort="Ludolph, A C" uniqKey="Ludolph A" first="A. C." last="Ludolph">A. C. Ludolph</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reske, S N" sort="Reske, S N" uniqKey="Reske S" first="S. N." last="Reske">S. N. Reske</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Landwehrmeyer, G B" sort="Landwehrmeyer, G B" uniqKey="Landwehrmeyer G" first="G. B." last="Landwehrmeyer">G. B. Landwehrmeyer</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0455135</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0455135 INIST</idno>
<idno type="RBID">Pascal:04-0455135</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002112</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Imaging of activated microglia with PET and [<sup>11</sup>
C]PK 11195 in corticobasal degeneration</title>
<author><name sortKey="Henkel, K" sort="Henkel, K" uniqKey="Henkel K" first="K." last="Henkel">K. Henkel</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Karitzky, J" sort="Karitzky, J" uniqKey="Karitzky J" first="J." last="Karitzky">J. Karitzky</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmid, M" sort="Schmid, M" uniqKey="Schmid M" first="M." last="Schmid">M. Schmid</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mader, I" sort="Mader, I" uniqKey="Mader I" first="I." last="Mader">I. Mader</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neuroradiology, University of Tübingen</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Glatting, G" sort="Glatting, G" uniqKey="Glatting G" first="G." last="Glatting">G. Glatting</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Unger, J W" sort="Unger, J W" uniqKey="Unger J" first="J. W." last="Unger">J. W. Unger</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Neumaier, B" sort="Neumaier, B" uniqKey="Neumaier B" first="B." last="Neumaier">B. Neumaier</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ludolph, A C" sort="Ludolph, A C" uniqKey="Ludolph A" first="A. C." last="Ludolph">A. C. Ludolph</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reske, S N" sort="Reske, S N" uniqKey="Reske S" first="S. N." last="Reske">S. N. Reske</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Landwehrmeyer, G B" sort="Landwehrmeyer, G B" uniqKey="Landwehrmeyer G" first="G. B." last="Landwehrmeyer">G. B. Landwehrmeyer</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Degeneration</term>
<term>Emission tomography</term>
<term>Microglia</term>
<term>Nervous system diseases</term>
<term>Positron</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dégénérescence</term>
<term>Microglie</term>
<term>Positon</term>
<term>Système nerveux pathologie</term>
<term>Tomoscintigraphie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Positron emission tomography (PET) using [<sup>11</sup>
C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [<sup>11</sup>
C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [<sup>11</sup>
C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>19</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Imaging of activated microglia with PET and [<sup>11</sup>
C]PK 11195 in corticobasal degeneration</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>HENKEL (K.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KARITZKY (J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SCHMID (M.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>MADER (I.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GLATTING (G.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>UNGER (J. W.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>NEUMAIER (B.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>LUDOLPH (A. C.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>RESKE (S. N.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>LANDWEHRMEYER (G. B.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Nuclear Medicine, University of Ulm</s1>
<s2>Ulm</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neuroradiology, University of Tübingen</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>817-821</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000113929420110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>13 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0455135</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Positron emission tomography (PET) using [<sup>11</sup>
C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [<sup>11</sup>
C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [<sup>11</sup>
C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dégénérescence</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Degeneration</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Degeneración</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Microglie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Microglia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Microglia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Positon</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Positron</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Positrón</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Tomoscintigraphie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Emission tomography</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Tomocentelleografía</s0>
<s5>05</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Névroglie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Neuroglia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Neuroglia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Exploration radioisotopique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Radionuclide study</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Exploración radioisotópica</s0>
<s5>38</s5>
</fC07>
<fN21><s1>257</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 04-0455135 INIST</NO>
<ET>Imaging of activated microglia with PET and [<sup>11</sup>
C]PK 11195 in corticobasal degeneration</ET>
<AU>HENKEL (K.); KARITZKY (J.); SCHMID (M.); MADER (I.); GLATTING (G.); UNGER (J. W.); NEUMAIER (B.); LUDOLPH (A. C.); RESKE (S. N.); LANDWEHRMEYER (G. B.)</AU>
<AF>Department of Neurology University of Ulm/Ulm/Allemagne (1 aut., 2 aut., 6 aut., 8 aut., 10 aut.); Department of Nuclear Medicine, University of Ulm/Ulm/Allemagne (1 aut., 2 aut., 3 aut., 5 aut., 7 aut., 9 aut.); Department of Neuroradiology, University of Tübingen/Tübingen/Allemagne (4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 7; Pp. 817-821; Bibl. 13 ref.</SO>
<LA>Anglais</LA>
<EA>Positron emission tomography (PET) using [<sup>11</sup>
C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [<sup>11</sup>
C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [<sup>11</sup>
C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD.</EA>
<CC>002B17</CC>
<FD>Dégénérescence; Microglie; Positon; Système nerveux pathologie; Tomoscintigraphie</FD>
<FG>Névroglie; Exploration radioisotopique</FG>
<ED>Degeneration; Microglia; Positron; Nervous system diseases; Emission tomography</ED>
<EG>Neuroglia; Radionuclide study</EG>
<SD>Degeneración; Microglia; Positrón; Sistema nervioso patología; Tomocentelleografía</SD>
<LO>INIST-20953.354000113929420110</LO>
<ID>04-0455135</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002112 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002112 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:04-0455135 |texte= Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration }}
This area was generated with Dilib version V0.6.23. |